These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 32517744

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters.
    Fernández L, Carrillo E, Sánchez-Sampedro L, Sánchez C, Ibarra-Meneses AV, Jimenez MA, Almeida VDA, Esteban M, Moreno J.
    Front Immunol; 2018; 9():843. PubMed ID: 29740446
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A, Ojeda A, López-Fuertes L, Timón M, Altet L, Solano-Gallego L, Sánchez-Robert E, Francino O, Alberola J.
    Vaccine; 2007 Nov 14; 25(46):7962-71. PubMed ID: 17942199
    [Abstract] [Full Text] [Related]

  • 5. Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice.
    Saljoughian N, Zahedifard F, Doroud D, Doustdari F, Vasei M, Papadopoulou B, Rafati S.
    Parasite Immunol; 2013 Dec 14; 35(12):397-408. PubMed ID: 23710803
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
    Ribeiro PAF, Dias DS, Lage DP, Costa LE, Martins VT, Tavares GSV, Mendonça DVC, Lima MP, Oliveira JS, Steiner BT, Machado-de-Ávila RA, Roatt BM, Chávez-Fumagalli MA, Menezes-Souza D, Duarte MC, Teixeira AL, Coelho EAF.
    Cell Immunol; 2018 Sep 14; 331():67-77. PubMed ID: 29871740
    [Abstract] [Full Text] [Related]

  • 7. A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis.
    Carson C, Antoniou M, Ruiz-Argüello MB, Alcami A, Christodoulou V, Messaritakis I, Blackwell JM, Courtenay O.
    Vaccine; 2009 Feb 11; 27(7):1080-6. PubMed ID: 19095029
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.
    Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S.
    J Immunol; 2005 Jun 01; 174(11):7160-71. PubMed ID: 15905560
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunization of Experimental Dogs With Salivary Proteins From Lutzomyia longipalpis, Using DNA and Recombinant Canarypox Virus Induces Immune Responses Consistent With Protection Against Leishmania infantum.
    Abbehusen MMC, Cunha J, Suarez MS, Teixeira C, Almeida VDA, Pereira LDS, Bordoni M, Gil-Santana L, Solcà MDS, Fraga DBM, Fischer L, Bozza PT, Veras PST, Valenzuela JG, Kamhawi S, Andrade BB, Brodskyn CI.
    Front Immunol; 2018 Jun 01; 9():2558. PubMed ID: 30519235
    [Abstract] [Full Text] [Related]

  • 14. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
    Petitdidier E, Pagniez J, Papierok G, Vincendeau P, Lemesre JL, Bras-Gonçalves R.
    PLoS Negl Trop Dis; 2016 May 01; 10(5):e0004614. PubMed ID: 27223609
    [Abstract] [Full Text] [Related]

  • 15. Development of dominant epitope-based vaccines encoding Gp63, Kmp-11 and Amastin against visceral leishmaniasis.
    Zhang J, He J, Liao X, Xiao Y, Liang C, Zhou Q, Chen H, Zheng Z, Qin H, Chen D, Chen Q, Li J, Chen J.
    Immunobiology; 2021 May 01; 226(3):152085. PubMed ID: 33910113
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA, Gannavaram S, Santiago Hda C, Selvapandiyan A, Souza DM, Passos LS, de Mendonça LZ, Lemos-Giunchetti Dda S, Ricci ND, Bartholomeu DC, Giunchetti RC, Bueno LL, Correa-Oliveira R, Nakhasi HL, Fujiwara RT.
    Vaccine; 2015 Jan 03; 33(2):280-8. PubMed ID: 25475955
    [Abstract] [Full Text] [Related]

  • 19. A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum.
    Pirdel L, Farajnia S.
    Scand J Immunol; 2017 Jul 03; 86(1):15-22. PubMed ID: 28426153
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.